Commercial laboratory IgM testing for Toxoplasma gondii in pregnancy: A 20-year experience

Infectious Diseases in Obstetrics and Gynecology

Volumn 13, Issue 3, 2005, Pages 151-153

  Garry, David J ^a   Elimian, Andrew ^a   Wiencek, Vandy ^a   Baker, David A ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Antibody; False positive; Perinatal infection

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOASSAY; LABORATORY TEST; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANIMALS; FEMALE; HUMANS; IMMUNOGLOBULIN M; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; TOXOPLASMA; TOXOPLASMOSIS;

EID: 26844576246     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1080/10647440500148024     Document Type: Article

References (12)

1. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: Seroprevalence and risk factors. Am J Epidem 2001;154:357-365.
2. Centers for Disease Control and Prevention. CDC recommendations regarding selected conditions affecting women's health. MMWR Morb Mortal Wkly Rep 2000;49(RR-2):57-75.
3. Kohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med 1994;331:695-699.
4. Foulon W, Villena I, Stray-Pederson B, Decoster A, Lappalainen M. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 1999;180:410-415.
5. Buzby JC, Roberts T. Ecomonic costs and trade impacts of microbial foodborne illness. World Health Stat Q 1997;50: 57-66.
6. Del Bono V, Canessa A, Bruzzi P, Fiorelli MA, Terragna A. Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy. J Clin Microbiol 1989;27:2133-2135.
7. Public Health Service, Department of Health and Human Services (US), Food and Drug Administration. FDA Public Health Advisory: limitations of Toxoplasmosis IgM commercial test kits [letter]. Washington: Department of Health and Human Services (US); 1997. (http://www.fda.gov/cdrh/toxopha.html)
8. Jones JL, Dietz VJ, Power M, Lopez A, Wilson M, Navin TR, Gibbs R, Schulkin J. Survey of obstetrician-gynecologists in the United States about toxoplasmosis. Infect Dis Obstet Gynecol 2001;9:23-31.
9. The American College of Obstetrician Gynecologists. Perinatal viral and parasitic infections. ACOG Practice Bulletin 2000,20 September 2000 Washington DC.
10. Zotti C, Charrier L, Giacomuzzi M, Moiraghi Ruggenini A, Mombro M, et al. Use of IgG Avidity test in case definitions of toxoplasmosis in pregnancy. New Microbiol 2004;27:17-20.
11. Dao A, Azzouz N, Eloundou Nga C, Dubremetz JF, Schwarz RT, Fortier B. Unspecific reactivity of IgM directed against the low-molecular-weight antigen of Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 2003;22:418-421.
12. Potasman I, Araujo FG, Remington JS. Toxoplasma antigens recognized by naturally occurring human antibodies. J Clin Microbiol. 1986;24:1050-1054.